RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia. 2000a; 2 :418–425.van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia . 2000; 2 (5):418–425....
This will impact on patient outcome. We will also study the predictive power of RhoC GTPase and WISP3 expression in the response of breast cancer to farnesyl transferase inhibitors, a new gene-targeted treatment modality for advanced cancers....
This will impact on patient outcome. We will also study the predictive power of RhoC GTPase and WISP3 expression in the response of breast cancer to farnesyl transferase inhibitors, a new gene-targeted treatment modality for advanced cancers.Kleer, C. GMichigan Univ....
RhoC GTPase Assay ActivationMichelle LuceyHeather UngerKenneth L. van Golen
Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1. Mol Cancer 4: 21, 2005.Regulation of pan-creatic cancer cell migration andinvasion by RhoC GTPase andcaveolin-1. Lin M,Di Vito MM,...
Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis 2002 ; 19 : 301 –311.van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is ...
(2012). Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase. Molecular Cancer Research 10(10): 1306-1318.Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL. Regulation of inflammatory breast cancer cell invasion ...
van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD: Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflam- matory breast cancer. Clin Exp Metastasis 19: 301-11, 2002...
Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. Int J Cancer 2011; 129:61-9.Chatterjee M & van Golen KL (2010) Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and...
RhoC Assay Activation GTPaseMichelle LuceyHeather UngerKenneth L. van Golen